KBI Biopharma, Inc. Announces Collaboration with Infinimmune Inc. to Support Antibody Manufacturing
Durham, North Carolina and Alameda, California (September 08, 2025) – KBI Biopharma, Inc. (KBI), a JSR Life Sciences company and cGMP contract...
Accelerating timelines vital to securing slice of biosimilars market, KBI
By Dan Stanton+, 24-Aug-2016
Accelerated development gives biosimilars an upper hand in gaining market share, CMO KBI Biopharma told delegates in Korea yesterday.
Durham, North Carolina and Alameda, California (September 08, 2025) – KBI Biopharma, Inc. (KBI), a JSR Life Sciences company and cGMP contract...
Durham, North Carolina (April 3, 2025) – KBI Biopharma, a JSR Life Sciences Company and leading global contract development and manufacturing...
KBI Biopharma Selected as CDMO of Choice to Fast-Track Development of Pre-Clinical Antibody for Blood Cancers Using SUREmAbTM Technology Durham,...